AMSTERDAM, May 7, 2012 /PRNewswire/ -- Core Laboratories N.V.

LONDON, April 2, 2012 /PRNewswire/ -- - (NYSE: RDS.A) (NYSE:RDS.B) Notification relating to a transaction notified in accordance with: DR 3.1.4 R(1)(a)

LONDON, March 16, 2012 /PRNewswire/ -- Royal Dutch Shell plc (the "Company") (NYSE: RDS.A) (NYSE: RDS.B) announces that application has been made to the UK Listing Authority

NIEUWEGEIN, The Netherlands, March 12, 2012 /PRNewswire/ -- As of 9 March 2011, the Supervisory Board has allocated options to the members of the Board of Management: 40,000

AMSTERDAM, December 15, 2011 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the Company